Page last updated: 2024-08-23

1-deoxynojirimycin and ambroxol

1-deoxynojirimycin has been researched along with ambroxol in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benjamin, ER; Boyd, RE; Khanna, R; Lee, G; Rybczynski, P; Valenzano, KJ; Wustman, BA	1
Beller, M; Giese, AK; Gläser, A; Lukas, J; Pockrandt, AM; Pohlers, S; Rolfs, A; Runge, F; Seemann, S; Sharif, M; Zheng, C	1
Christy, JP; George Priya Doss, C; Iyer, S; Siva, R; Tayubi, IA; Thirumal Kumar, D; Zayed, H	1

Reviews

2 review(s) available for 1-deoxynojirimycin and ambroxol

Article	Year
Pharmacological chaperones as therapeutics for lysosomal storage diseases. Journal of medicinal chemistry, 2013, Apr-11, Volume: 56, Issue:7 Topics: Cell Line; Glycolipids; Humans; Lysosomal Storage Diseases; Molecular Chaperones; Structure-Activity Relationship	2013
A comparative computational approach toward pharmacological chaperones (NN-DNJ and ambroxol) on N370S and L444P mutations causing Gaucher's disease. Advances in protein chemistry and structural biology, 2019, Volume: 114 Topics: 1-Deoxynojirimycin; Ambroxol; Gaucher Disease; Glucosylceramidase; Humans; Models, Molecular; Molecular Chaperones; Mutation	2019

Other Studies

1 other study(ies) available for 1-deoxynojirimycin and ambroxol

Article	Year
Enzyme enhancers for the treatment of Fabry and Pompe disease. Molecular therapy : the journal of the American Society of Gene Therapy, 2015, Volume: 23, Issue:3 Topics: 1-Deoxynojirimycin; Acetylcysteine; alpha-Galactosidase; alpha-Glucosidases; Ambroxol; Bezafibrate; Enzyme Activators; Fabry Disease; Gene Expression; Glycogen Storage Disease Type II; HEK293 Cells; Humans; Leupeptins; Lysosomes; Pioglitazone; Plasmids; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Stability; Recombinant Proteins; Thiazolidinediones; Transfection	2015

Article

Year

Enzyme enhancers for the treatment of Fabry and Pompe disease.

Molecular therapy : the journal of the American Society of Gene Therapy, 2015, Volume: 23, Issue:3

Topics: 1-Deoxynojirimycin; Acetylcysteine; alpha-Galactosidase; alpha-Glucosidases; Ambroxol; Bezafibrate; Enzyme Activators; Fabry Disease; Gene Expression; Glycogen Storage Disease Type II; HEK293 Cells; Humans; Leupeptins; Lysosomes; Pioglitazone; Plasmids; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Stability; Recombinant Proteins; Thiazolidinediones; Transfection

2015